Industry Analysis

  According to MRFR analysis,  ACE Inhibitors Market  is expected to register a CAGR of 3.10% during the forecast period and is likely to be valued at USD 7682.8 Million. The growth of the global ACE inhibitors market is determined by numerous factors such as rising adoption of ACE inhibitors for the treatment of cardiovascular complications and diabetic neuropathy, rising cases of cardiovascular disorders such as hypertension, and surge in demand for less expensive drugs. For instance, according to the data published by the World Health Organization (WHO) in 2017, the global prevalence rate of raised blood pressure in adults aged more than 18 was estimated to be 22.1% in 2017. However, ace inhibitors side effects associated with the treatment and high costs of treatment are likely to hamper the growth of the global ACE inhibitors market during the forecast period.  Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacif...

  According to MRFR analysis,  Life Science Analytics Market  is expected to register a CAGR of 11.91% during the forecast period and was valued at USD 19,165.22 Million in 2018. Life science analytics is a tool that helps in clinical trials standardization and optimization of the drug discovery process. The growth of the global life science analytics market can be contributed to growing pressure to curb the healthcare expenditure, need for improved data standardization, and increasing prevalence of chronic diseases. Furthermore, the growing adoption of analytics solutions in clinical trials, increasing adoption of analytics tools for sales & marketing applications, the need for improved patient outcomes, and rising adoption of big data in the life science industry are also expected to fuel the market growth during the forecast period. However, high implementation costs and lack of skilled professionals have expected to restrain the growth of the global life scien...

  According to MRFR analysis,  Vertigo Treatment Market  is expected to register a CAGR of 4.2% during the forecast period and accounts for USD 1,800 million in 2018. Vertigo refers to a sense of spinning dizziness that can be caused by problems in the brain or inner ear, including sudden head movements, or inflammation in the inner ear due to a viral or bacterial infection. Vertigo can be treated with medications such as steroids that can reduce internal ear inflammation, and water pills that can reduce fluid buildup in the ear. The growth of the global vertigo treatment market is driven by various factors such as an increase in the prevalence of vertigo, increasing geriatric population, and rising government initiatives to create awareness of the market. However, lack of knowledge about the vertigo symptoms and causes of is projected to hamper the growth of the global vertigo treatment market. The global vertigo treatment market is currently dominated by several ...

  According to MRFR analysis , Hip Implants Market  is expected to register a CAGR of 4.1 %  during the forecast period and is expected to reach USD 9,300 Million by 2025. Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis.  Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market. Several market players currently dominat...

  According to MRFR analysis,  Vitiligo Treatment Market  is expected to register a CAGR of 5.6% during the forecast period was valued at USD 1.22 Billion in 2018. Vitiligo is a skin disorder that causes white patches to appear on the skin. These patches occur because the melanocytes are destroyed, leaving areas of skin with no pigment at all. It can affect any skin part of the body. The growth of the global vitiligo treatment market is driven by various factors such as emerging therapies for skin disorders, increasing healthcare expenditure, lifestyle changes. However, the lack of skilled professionals is expected to curb the growth of the global vitiligo treatment market. Several market players currently dominate the global vitiligo treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, Incyte Corporation reported positive results from the study of ruxolitinib cream which ...

  According to MRFR analysis, the global  liver cirrhosis treatment market  is expected to register a CAGR of ~5.2% during the forecast period and was valued at USD 956.89 million in 2018. The growth of the global liver cirrhosis treatment market is driven by various factors such as an increasing global geriatric population, rising prevalence of liver cirrhosis, rapidly changing lifestyle, growing awareness programs regarding liver diseases, rising R&D investment for the development of innovative drugs for liver diseases, and increasing demand for better treatment methods for curing liver cirrhosis. However, stringent government regulations, high investment required for drug research & development, and side-effects of medications prescribed for liver cirrhosis are the factors that are expected to limit the growth of the global liver cirrhosis treatment market. Liver cirrhosis is basically the late-stage scarring of the liver caused due to various types of live...

  The Global Onychomycosis Market is expected to register a CAGR of 6.28% during the forecast period with a market value of USD 7,912.5 Million till 2025. Onychomycosis is a general term used to denote any fungal nail infection. Factors such as the surging diabetic patient population, rising per capita healthcare expenditure coupled with the rising occurrences of onychomycosis, are anticipated to fuel the growth of the global onychomycosis market. However, the lack of awareness about onychomycosis and the side-effects associated with onychomycosis treatment drugs is likely to hamper the market growth. Segment Analysis The global onychomycosis market, by type, has been divided into distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO) , proximal subungual onychomycosis (PSO), candida onychomycosis, and others. On the basis of treatment type, the global onychomycosis market has been divided into drug treatment, topical therapy, and others. The glo...

  The Global Cardiomyopathy Medication Market is anticipated to reach USD 620 Million by 2025 at a CAGR of ~4.60% during the forecast period. Cardiomyopathy is a disease that causes the thickening and enlargement of the heart muscles and abnormal blood flow. Patients suffering from cardiomyopathy showcase symptoms such as dizziness, coughing, fatigue, and swelling of the legs, ankles, and feet. Certain factors that propel the growth of the global cardiomyopathy medication market are the high patient pool of heart disease, focus on manufacturing medication for cardiomyopathy treatment, and rising healthcare expenditure.  Currently, the global cardiomyopathy medication market is dominated by several players. The major players in this market are involved in strategic acquisitions and product launches to expand their product portfolios. For instance, in May 2019, Pfizer Inc. received US FDA approval for Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) for the treatme...

  According to MRFR analysis, the global  implantable cardioverter defibrillator (ICD) market  is expected to register a CAGR of 5.96% during the forecast period. Implantable Cardioverter Defibrillator (ICD) is used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart. Factors such as the growing aging population, changing lifestyles such as smoking and alcohol consumption, and the increase in demand for cardiac implants are responsible for the increasing prevalence of cardiac arrhythmias globally. This is likely to fuel the growth of the ICD market during the forecast period. In addition to this, improving efficacy of ICDs for the treatment of cardiac diseases over a period will also fuel the market. According to the American Heart Association, approximately 1.5 million cases of myocardial infarction occur annually, and the incidence rate is approximately 600 cases per 100,000 people in the US. Accordin...

  The global  telehealth market  is growing pervasively mainly due to the range of advantages the telehealth it offers. Main five benefits of telehealth include improved outcomes, enhanced care-coordination that maximizes clinical efficiency driving consumer engagement, and all this at much-reduced costs. The uptake of Telehealth is on the rise as more users view telehealth as a viable alternative to traditional, in-person visits. As patients’ acceptance increases, the telehealth market will be evaluated in terms of value. Acknowledging the potential of the market to increase further, Market Research Future (MRFR) in its recently published study report asserts that the global telehealth market will perceive a splendid growth by 2023 registering a double-digit CAGR of 29.8% during the forecast. The patients' journey is unlikely to change since users of telehealth services will need to be seamlessly integrated into the familiar payer/provider constructs (access, reimburs...